These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 24586462)

  • 1. CMTM3 inhibits human testicular cancer cell growth through inducing cell-cycle arrest and apoptosis.
    Li Z; Xie J; Wu J; Li W; Nie L; Sun X; Tang A; Li X; Liu R; Mei H; Wang F; Wang Z; Gui Y; Cai Z
    PLoS One; 2014; 9(2):e88965. PubMed ID: 24586462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CMTM3 inhibits cell growth and migration and predicts favorable survival in oral squamous cell carcinoma.
    Zhang H; Zhang J; Nan X; Li X; Qu J; Hong Y; Sun L; Chen Y; Li T
    Tumour Biol; 2015 Sep; 36(10):7849-58. PubMed ID: 25946973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CMTM3, located at the critical tumor suppressor locus 16q22.1, is silenced by CpG methylation in carcinomas and inhibits tumor cell growth through inducing apoptosis.
    Wang Y; Li J; Cui Y; Li T; Ng KM; Geng H; Li H; Shu XS; Li H; Liu W; Luo B; Zhang Q; Mok TS; Zheng W; Qiu X; Srivastava G; Yu J; Sung JJ; Chan AT; Ma D; Tao Q; Han W
    Cancer Res; 2009 Jun; 69(12):5194-201. PubMed ID: 19509237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CMTM3 is reduced in prostate cancer and inhibits migration, invasion and growth of LNCaP cells.
    Hu F; Yuan W; Wang X; Sheng Z; Yuan Y; Qin C; He C; Xu T
    Clin Transl Oncol; 2015 Aug; 17(8):632-9. PubMed ID: 25990505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Re: CMTM3 Inhibits Human Testicular Cancer Cell Growth through Inducing Cell-Cycle Arrest and Apoptosis.
    Richie JP
    J Urol; 2015 Sep; 194(3):706-7. PubMed ID: 26292862
    [No Abstract]   [Full Text] [Related]  

  • 6. CMTM3 is frequently reduced in clear cell renal cell carcinoma and exhibits tumor suppressor activities.
    Xie J; Yuan Y; Liu Z; Xiao Y; Zhang X; Qin C; Sheng Z; Xu T; Wang X
    Clin Transl Oncol; 2014 Apr; 16(4):402-9. PubMed ID: 23907292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-135b-5p promotes gastric cancer progression by targeting CMTM3.
    Lu M; Huang Y; Sun W; Li P; Li L; Li L
    Int J Oncol; 2018 Feb; 52(2):589-598. PubMed ID: 29345297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CMTM3 inhibits cell migration and invasion and correlates with favorable prognosis in gastric cancer.
    Su Y; Lin Y; Zhang L; Liu B; Yuan W; Mo X; Wang X; Li H; Xing X; Cheng X; Dong B; Hu Y; Du H; Zhu Y; Ding N; Li J; Liu W; Ma Y; Qiu X; Ji J; Han W
    Cancer Sci; 2014 Jan; 105(1):26-34. PubMed ID: 24131472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CMTM3 overexpression promotes cell apoptosis while DHT promotes cell proliferation in hair follicle stem cells (HFSCs).
    Wang Q; Zhang L; Ji D; Qu J; Wang J; Zhang H; Li Y
    Genomics; 2021 Mar; 113(2):463-473. PubMed ID: 33358944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The ubiquitin peptidase UCHL1 induces G0/G1 cell cycle arrest and apoptosis through stabilizing p53 and is frequently silenced in breast cancer.
    Xiang T; Li L; Yin X; Yuan C; Tan C; Su X; Xiong L; Putti TC; Oberst M; Kelly K; Ren G; Tao Q
    PLoS One; 2012; 7(1):e29783. PubMed ID: 22279545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CMTM3 decreases EGFR expression and EGF-mediated tumorigenicity by promoting Rab5 activity in gastric cancer.
    Yuan W; Liu B; Wang X; Li T; Xue H; Mo X; Yang S; Ding S; Han W
    Cancer Lett; 2017 Feb; 386():77-86. PubMed ID: 27867015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated methylation of CMTM3 promoter in the male laryngeal squamous cell carcinoma patients.
    Shen Z; Chen X; Li Q; Zhou C; Xu Y; Yu R; Ye H; Li J; Duan S
    Clin Biochem; 2016 Nov; 49(16-17):1278-1282. PubMed ID: 27521994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CMTM3 Suppresses Proliferation and Osteogenic Transdifferentiation of C2C12 Myoblasts through p53 Upregulation.
    Shen E; Piao M; Li Y; Wu Y; Li S; Lee SH; Jin L; Lee KY
    Cells; 2024 Aug; 13(16):. PubMed ID: 39195242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CMTM3 (CKLF-Like Marvel Transmembrane Domain 3) Mediates Angiogenesis by Regulating Cell Surface Availability of VE-Cadherin in Endothelial Adherens Junctions.
    Chrifi I; Louzao-Martinez L; Brandt M; van Dijk CGM; Burgisser P; Zhu C; Kros JM; Duncker DJ; Cheng C
    Arterioscler Thromb Vasc Biol; 2017 Jun; 37(6):1098-1114. PubMed ID: 28428220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CKLF-Like MARVEL Transmembrane Domain-Containing Member 3 (CMTM3) Inhibits the Proliferation and Tumorigenisis in Hepatocellular Carcinoma Cells.
    Li W; Zhang S
    Oncol Res; 2017 Jan; 25(2):285-293. PubMed ID: 27629543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel 3p22.3 gene CMTM7 represses oncogenic EGFR signaling and inhibits cancer cell growth.
    Li H; Li J; Su Y; Fan Y; Guo X; Li L; Su X; Rong R; Ying J; Mo X; Liu K; Zhang Z; Yang F; Jiang G; Wang J; Zhang Y; Ma D; Tao Q; Han W
    Oncogene; 2014 Jun; 33(24):3109-18. PubMed ID: 23893243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Research Advances in CKLFSF-like MARVEL Transmembrane Domain Containing Member 3.
    Hu FZ; Sheng ZZ; Qin CP; Xu T
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2016 Jun; 38(3):360-3. PubMed ID: 27469927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knockdown of CMTM3 promotes metastasis of gastric cancer via the STAT3/Twist1/EMT signaling pathway.
    Yuan W; Li T; Mo X; Wang X; Liu B; Wang W; Su Y; Xu L; Han W
    Oncotarget; 2016 May; 7(20):29507-19. PubMed ID: 27121055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Knockdown of CMTM3 promotes migration and invasion of PC3 cell in vitro].
    Hu FZ; Yuan WQ; Wang XL; Qin CP; Sheng ZZ; DU YQ; Yin HQ; Xu T
    Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Aug; 48(4):594-597. PubMed ID: 29263495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CMTM3 deficiency induces cardiac hypertrophy by regulating MAPK/ERK signaling.
    Ye J; Yan S; Liu R; Weng L; Jia B; Jia S; Xiong Y; Zhou Y; Leng M; Zhao J; Yang F; Zheng M
    Biochem Biophys Res Commun; 2023 Jul; 667():162-169. PubMed ID: 37229825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.